CannLabs, Inc.
CANLOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$93317
P/E Ratio—
52W High$0.01
52W Low$0.0001
CannLabs, Inc. (CANL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CANL · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.39M | $3.18M | $2.77M | $2.50M | $1.36M |
| Cost of Revenue | $2.33M | $1.48M | $1.52M | $1.05M | $0.89M |
| Gross Profit | $2.06M | $1.70M | $1.25M | $1.45M | $0.48M |
| Gross Margin %(computed) | 46.97% | 53.39% | 45.05% | 57.90% | 35.03% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $1.19M | $0.98M | $0.72M | $0.64M | $3.67M |
| Operating Income | $0.87M | $0.71M | $0.52M | $0.80M | ($3.19M) |
| Operating Margin %(computed) | 19.86% | 22.45% | 18.88% | 32.19% | -233.57% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.05M |
| Income Before Tax | $0.87M | $0.71M | $0.52M | $0.80M | ($3.24M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $0.87M | $0.71M | $0.52M | $0.80M | ($1.58M) |
| Net Margin %(computed) | 19.79% | 22.41% | 18.83% | 32.16% | -116.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.01 | $-0.03 |
| Wtd Avg Shares | 813.16M | 813.16M | 463.16M | 62.16M | 60.32M |
| EBITDA | $0.88M | $0.72M | $0.53M | $0.81M | ($2.96M) |
| EBITDA Margin %(computed) | 20.05% | 22.72% | 19.19% | 32.44% | -217.11% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more CannLabs, Inc. data
About CannLabs, Inc. (CANL) Income Statement
CannLabs, Inc. (CANL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, CANL reported revenue of $0.00B, gross profit of $0.00B (gross margin 46.97%), and net income of $0.00B — a net profit margin of 19.79%.
Frequently asked questions
CANL · 4 questionsCannLabs, Inc. (CANL) reported revenue of $0.00B for 2022, up 38.0% year-over-year.
CANL revenueCANL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09